Medical and surgical instruments, equipment, and supplies
Ended Awarded Last action
- Contract number
- FA660626FG021
- Awardee
-
Biospace, Inc. UEI MTGTVFNHLF74
- Awarding agency
-
Reserve Command
Air Force, Department of Defense
- Obligated
- $16,152
Award facts
- Contract value 100% obligated
- $16,152.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicopee, MA 01022, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,152.20, was awarded on October 1, 2025, to Biospace, Inc. (doing business as Inbody) for the provision of medical and surgical instruments, equipment, and supplies. The award was issued without a set-aside designation and is funded by the U.S. Reserve Command, a Defense agency component. Performance will be executed in Chicopee, Massachusetts, with a firm fixed price structure and an ultimate completion date of September 30, 2026. Biospace, a foreign-owned, minority-owned, Asian-Pacific American-owned company headquartered in Cerritos, California, specializes in advanced body composition analyzers and bioelectrical impedance analysis technology, including its InBody product line of sophisticated medical devices.
This delivery order is issued under the Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), one of three primary indefinite-delivery contract vehicles under which Biospace currently operates. The General Services Administration's Federal Acquisition Service awarded the underlying GSA Multiple Award Schedule contract on June 7, 2021, with completion scheduled for June 6, 2026. Biospace has established itself as a leading federal supplier across the Department of Defense and civilian agencies, with recent significant awards including $1.69 million from the Marine Corps in September 2025 and $2.34 million from the Army for InBody 770 bioelectrical impedance analysis devices. The company maintains proven delivery capability across military and civilian health organizations, including the Defense Health Agency, Service branches, and Veterans Integrated Service Networks.
Quick answers
Who was awarded contract FA660626FG021?
FA660626FG021 was awarded to Biospace, Inc. by Reserve Command (Air Force) on October 1, 2025.
How much is contract FA660626FG021 worth?
The government has obligated $16,152 on FA660626FG021.
Is contract FA660626FG021 an order under another contract?
Yes. FA660626FG021 is a delivery order under 36F79722D0074, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract FA660626FG021 competed?
The extent of competition for FA660626FG021 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award